<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1411">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 10, 2022</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03508024</url>
  </required_header>
  <id_info>
    <org_study_id>NI_2016_39</org_study_id>
    <secondary_id>2017-A00486-47</secondary_id>
    <nct_id>NCT03508024</nct_id>
  </id_info>
  <brief_title>Patients With Alzheimer's Disease or Related Youth Disease</brief_title>
  <acronym>PARMAAJJ</acronym>
  <official_title>Patients With Alzheimer's Disease or Related Youth Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Lille</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Lille</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to determine factors related to diagnosis delay for patients with young onset&#xD;
      dementia (first symptoms before 60 years old) who live in North of France.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 5, 2018</start_date>
  <completion_date type="Actual">April 25, 2019</completion_date>
  <primary_completion_date type="Actual">April 25, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>the delay between the diagnosis and the first symptomsIdentification of factors related with diagnosis delay</measure>
    <time_frame>10 years</time_frame>
    <description>To determine the factors associated with diagnostic delay in young patients (early symptoms before age 60) with Alzheimer's disease or related degenerative disease (Fronto-temporal Lobar Degeneration , Lewy Body Dementia )</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Comparison of patient profiles followed at the CMRR-CNR-MAJ Lille and those who are not.</measure>
    <time_frame>10 years</time_frame>
    <description>The different profiles are defined according to composite measures of socio-demographic type</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparison of patients characteristics followed at the CMRR-CNR-MAJ Lille and those who are not.Impact of the diagnosis on YOD</measure>
    <time_frame>10 years</time_frame>
    <description>The different characteristics are defined according to composite measures of socio-demographic type</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the percentage of patients who have had a lack of information about the disease and possible aids</measure>
    <time_frame>10 years</time_frame>
    <description>Identification of medico-social issues taht have been encountered by YOD patients during the care</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the percentage of refusal or delay of treatment of certain medico-social aids by the competent authorities</measure>
    <time_frame>10 years</time_frame>
    <description>Identification of medico-social issues taht have been encountered by YOD patients during the care</description>
  </secondary_outcome>
  <enrollment type="Actual">220</enrollment>
  <condition>Alzheimer Disease, Early Onset</condition>
  <condition>Lewy Body Disease</condition>
  <condition>Frontotemporal Lobar Degeneration</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with a diagnosis of Alzheimer disease, Lewy Bodies Dementia or FrontoTemporal&#xD;
        Lobar Degeneration and their caregivers&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        As part of this study, patients will be considered:&#xD;
&#xD;
          -  Residing in the departments of Nord (59) and Pas-de-Calais (62),&#xD;
&#xD;
          -  whose diagnosis of Alzheimer's disease or related illness (DLFT, DCL) was made and&#xD;
             announced,&#xD;
&#xD;
          -  Whose diagnosis of illness was made after 2007&#xD;
&#xD;
          -  whose first symptoms appeared before the age of 60 Patients included in the COMAJ&#xD;
             cohort and those who completed the Pathways medical and social booklet will have to&#xD;
             meet these criteria to be selected for this study.&#xD;
&#xD;
        As part of the survey, caregivers of patients meeting the above criteria and the following&#xD;
        two will be recruited:&#xD;
&#xD;
          -  Having consulted or being followed by liberal neurologists or in hospital memory&#xD;
             consultations (excluding CMRR-CNR-MAJ Lille) of the departments of Nord and&#xD;
             Pas-de-Calais,&#xD;
&#xD;
          -  Not monitored at the CMRR-CNR-MAJ Lille (ad hoc notice possible). The caregiver is&#xD;
             defined as a family member or friend who helps regularly by doing the necessary tasks&#xD;
             so that the sick person can keep as much autonomy as possible.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  aged under 18&#xD;
&#xD;
          -  no social coverage&#xD;
&#xD;
          -  refusal to sign informed consent form&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Florence Pasquier, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Lille</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>HÃ´pital Roger Salengro, CHRU</name>
      <address>
        <city>Lille</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <study_first_submitted>November 8, 2017</study_first_submitted>
  <study_first_submitted_qc>April 24, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 25, 2018</study_first_posted>
  <last_update_submitted>March 24, 2021</last_update_submitted>
  <last_update_submitted_qc>March 24, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alzheimer Disease</mesh_term>
    <mesh_term>Lewy Body Disease</mesh_term>
    <mesh_term>Frontotemporal Lobar Degeneration</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

